Tuberculosis

Research News


Research sets new standard for treating latent tuberculosis in Canada
March 24, 2022 - A transformational treatment for latent tuberculosis (TB) is now the standard of care in Canada, thanks to research led by The Ottawa Hospital. The Canadian Thoracic Society’s new Canadian TB Standards, released on March 24, 2022, recommend 3HP (rifa
Researchers at The Ottawa Hospital awarded 18 CIHR grants worth more than $11 million
February 5, 2022 - These projects will advance science and improve health in areas such as tuberculosis, blood disease, prostate cancer, heart disease, muscle repair, sleep apnea, brain cancer, medical imaging, virtual care, prehab, intellectual disability, sarcoma, CA
The Ottawa Hospital awarded 13 grants worth $11.2 million from Canadian Institutes of Health Research
July 26, 2019 - Researchers at The Ottawa Hospital have been awarded 13 grants worth a total of $11.2 million from the Canadian Institutes of Health Research (CIHR). The new projects focus on areas such as cancer immunotherapy, hepatitis C infection, blood clots, ar
Show more news stories


Researchers


Name Scientific appointment Diseases, conditions and populations of interest Research and clinical approaches
Alvarez, Gonzalo
MD, MPH, FRCPC
Scientist
(Clinical Epidemiology)
First Nations, Inuit and Métis Health, Health in disadvantaged peoples, Infectious disease, Lung disease, Population health, Tuberculosis Clinical research, Patient engagement
Cameron, Bill
MD, FRCPC, FACP
Senior Scientist
(Clinical Epidemiology)
Chronic disease, Chronic obstructive pulmonary disease, COVID-19, Cystic fibrosis, HIV, Infectious disease, Sexually transmitted infections, Tuberculosis Clinical research, Epidemiology, Immunization, Immunotherapy, Pharmacology